a potential novel hemophilia treatment: an in vitro study of eptacog beta and emicizumab
Published 3 years ago • 101 plays • Length 4:57Download video MP4
Download video MP3
Similar videos
-
0:59
the safety and efficacy of etavopivat in scd
-
2:36
safety and preliminary efficacy of elotuzumab and belantamab mafodotin in patients with r/r myeloma
-
2:29
the safety and feasibility of car-t & bispecifics in patients with myeloma after prior allosct
-
1:47
trials exploring the safety and efficacy of modakafusp alfa in r/r multiple myeloma: iinnovate
-
4:41
association of host hematopoiesis with car-t hematotoxicity and efficacy in lbcl
-
2:33
the effect of lymphodepleting agents on rate and severity of toxicities following car-t infusion
-
3:02
the impact of conditioning intensity on vod/sos severity and outcomes in patients undergoing sct
-
3:23
patient characteristics and outcomes of allosct for bpdcn
-
3:51
sickle cell disease | moa animation
-
1:43
id 175 west tbm manimangalam road walkable distance gajalakshmi nagar 2400 2 plot available
-
15:08
hemostasis and coagulation absite review
-
1:03
late effect surveillance following allosct: the publication of new guidelines
-
4:04
results of phase ii trial to assess the efficacy and safety of idelalisib
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
1:06
overview of the diagnostic work-up for hemophilia
-
3:49
the impact of allosct versus blood transfusion & iron chelation on the qol of patients with tdt
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
1:27
preventing and monitoring cardiotoxicities associated with treatment for hematologic malignancies
-
3:36
the long-term outcomes of consolidative allosct for bpdcn
-
3:40
master class in transplantation and hematology: highlights
-
8:57
outcomes of sct in t-all and t-lbl